Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Strong Sell

Debt to Equity Rating

Strong Buy

Price to Earnings Rating

Sell

Analyst Rating

Neutral

Orchard Therapeutics plc American Depositary Shares (ORTX)

Biological Products, (no Disgnostic Substances)

https://www.orchard-tx.com

Orchard Therapeutics PLC is a United Kingdom-based commercial-stage, a fully-integrated biopharmaceutical company. The company is engaged in transforming the lives of patients with serious and life-threatening rare diseases through autologous ex vivo gene therapies. It operates in three geographic regions: the United Kingdom, European Union, and the United States. Orchard Rx is focusing on its autologous ex vivo gene therapy approach on three therapeutic rare disease franchise areas: primary immune deficiencies, neurometabolic disorders, and hemoglobinopathies. Its portfolio includes Strimvelis, used for the treatment of ADA-SCID five lentiviral product candidates.

245 HAMMERSMITH ROAD, 3RD FLOOR
LONDON, X0

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

10/31/2018

Market Cap

380,108,700

Shares Outstanding

181,910,000

Weighted SO

22,761,044

Total Employees

N/A

Upcoming Earnings

N/A

Beta

0.5530

Last Div

0.0000

Range

4.24-16.72

Chg

0.0500

Avg Vol

105224

Mkt Cap

380108700

Exch

NASDAQ

Country

GB

Phone

44 20 3 808 8286

DCF Diff

N/A

DCF

1.5744

Div Yield

0.0000

P/S

17.4050

EV Multiple

5.5403

P/FV

4.7523

Div Yield %

0.0000

P/E

5.4599

PEG

0.0690

Payout

0.0000

Current Ratio

3.1174

Quick Ratio

2.8321

Cash Ratio

0.4753

DSO

241.0213

DIO

1011.2145

Op Cycle

1252.2359

DPO

557.7066

CCC

694.5293

Gross Margin

0.8903

Op Margin

2.8688

Pretax Margin

3.2493

Net Margin

3.1987

Eff Tax Rate

-0.0119

ROA

0.3454

ROE

0.7179

ROCE

0.4098

NI/EBT

0.9844

EBT/EBIT

1.1326

EBIT/Rev

2.8688

Debt Ratio

0.2364

D/E

0.5958

LT Debt/Cap

0.2904

Total Debt/Cap

0.3734

Int Coverage

-294.1362

CF/Debt

-1.9514

Equity Multi

2.5202

Rec Turnover

1.5144

Pay Turnover

0.6545

Inv Turnover

0.3610

FA Turnover

0.8049

Asset Turnover

0.1080

OCF/Share

-4.0859

FCF/Share

-4.1337

Cash/Share

5.4912

OCF/Sales

-4.2730

FCF/OCF

1.0117

CF Coverage

-1.9514

ST Coverage

-6.2307

CapEx Coverage

-85.3769

Div&CapEx Cov

-85.3769

P/BV

4.7523

P/B

4.7523

P/S

17.4050

P/E

5.4599

P/FCF

-4.0261

P/OCF

-4.0872

P/CF

-4.0872

PEG

0.0690

P/S

17.4050

EV Multiple

5.5403

P/FV

4.7523

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation